Ludwik, K. A., Campbell, J. P., Li, M., Li, Y., Sandusky, Z. M., Pasic, L., . . . Lannigan, D. A. (2016). Development of a RSK Inhibitor as a Novel Therapy for Triple Negative Breast Cancer. Mol Cancer Ther.
Chicago ZitierstilLudwik, Katarzyna A., et al. "Development of a RSK Inhibitor As a Novel Therapy for Triple Negative Breast Cancer." Mol Cancer Ther 2016.
MLA ZitierstilLudwik, Katarzyna A., et al. "Development of a RSK Inhibitor As a Novel Therapy for Triple Negative Breast Cancer." Mol Cancer Ther 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.